周五盘中，ANI制药（ANI Pharmaceuticals, Inc.，股票代码：ANIP）股价大幅上涨5.29%，引发市场关注。这一显著涨幅主要源于公司发布的强劲第三季度财报以及上调的全年收入预期。
根据公司公布的财务报告，ANI制药第三季度业绩表现亮眼。每股收益达到2.04美元，远超分析师平均预期的1.75美元。同时，公司第三季度收入也超出预期，达到2.1104亿美元，高于市场预估。这一优异表现反映了公司在运营和市场拓展方面的成效。
更值得注意的是，ANI制药上调了2025财年的收入指引。公司现预计全年营收将在8.54亿至8.73亿美元之间，较此前8.18亿至8.43亿美元的预期有明显提升。这一调整显示出管理层对公司未来业绩增长的信心，也是推动股价上涨的重要因素。分析师们普遍认为，这一上调后的指引仍具有一定的保守性，可能为未来的正面惊喜留下空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.